Publisher： Bentham Science Publishers
E-ISSN： 1873-4286|20|28|4565-4569
ISSN： 1381-6128
Source： Current Pharmaceutical Design, Vol.20, Iss.28, 2014-08, pp. : 4565-4569
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Although several studies have been published on the gut microbiota composition, they are mainly focused on bacteria. Therefore, the world of gut yeasts, the “gut mycome”, is still unclear. Over the last years, brand new gut microbiota analysis techniques have been applied to the study of yeasts, with exciting results both in health and in disease. A therapeutic potential for many gastrointestinal and extra-intestinal diseases has been recognized for selected yeast strains, such as Saccharomyces boulardii. This narrative review represents an overview of the new evidences regarding the “gut mycome”.
Related content
The Role of Gut Microbiota in Drug Response
Current Pharmaceutical Design, Vol. 15, Iss. 13, 2009-05 ,pp. :
Access to resources
Recommend
The Gut Microbiota in Inflammatory Bowel Disease
Current Pharmaceutical Design, Vol. 15, Iss. 13, 2009-05 ,pp. :